Boston Scientific Q4 Adj. EPS Guidance $0.49 - $0.52 Vs. $0.52 Estimate; GAAP EPS Guidance $0.26 - $0.30
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has released its Q4 adjusted EPS guidance, which is expected to be between $0.49 and $0.52, compared to the estimate of $0.52. The GAAP EPS guidance is between $0.26 and $0.30.
October 26, 2023 | 10:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Boston Scientific's Q4 adjusted EPS guidance is slightly lower than the estimate, which could potentially impact the company's stock negatively in the short term.
Earnings per share (EPS) is a key indicator of a company's profitability. A lower than expected EPS often leads to a decrease in the company's stock price as it indicates that the company may not be as profitable as expected. In this case, Boston Scientific's adjusted EPS guidance is slightly lower than the estimate, which could potentially lead to a decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100